ArticleBMC endocrine disorders2019

Long-term outcomes and risk factors of thyroid dysfunction during pegylated interferon and ribavirin treatment in patients with chronic hepatitis C infection in Taiwan.

Yu-Kang Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.